Venkatakrishnan, K., Gupta, N., Smith, P. F., Lin, T., Lineberry, N., Ishida, T., . . . Rogge, M. (2023). Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo. Clinical pharmacology and therapeutics, 113(2), 298-309. https://doi.org/10.1002/cpt.2591
Citace podle Chicago (17th ed.)Venkatakrishnan, Karthik, Neeraj Gupta, Patrick F. Smith, Tiffany Lin, Neil Lineberry, Tatiana Ishida, Lin Wang, a Mark Rogge. "Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo." Clinical Pharmacology and Therapeutics 113, no. 2 (2023): 298-309. https://doi.org/10.1002/cpt.2591.
Citace podle MLA (9th ed.)Venkatakrishnan, Karthik, et al. "Asia‐Inclusive Clinical Research and Development Enabled by Translational Science and Quantitative Clinical Pharmacology: Toward a Culture That Challenges the Status Quo." Clinical Pharmacology and Therapeutics, vol. 113, no. 2, 2023, pp. 298-309, https://doi.org/10.1002/cpt.2591.